From Name:
From Email:
To Name:
To Email:

Optional Message:


Is Pharmaceutical Biotech Investment At Risk?

from By Mike Wokasch

OK. I'm not an analyst, at least not the certified financial type, but I believe there is a very disconcerting trend evolving in the financial markets. I wrote about this previously but I limited my attention at the time to startup biotech funding. I now feel the issue may have a profound effect on all Big Pharma and biotech. What am I talking about? Investor obsession with short term quick returns. Perhaps this isn't new, but it is certainly heightened in seriousness with the recent Facebook acquisition of WhatsApp, which also highlights why this trend is likely to continue. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063